期刊
ACTA TROPICA
卷 215, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.actatropica.2020.105805
关键词
Amphotericin B; Leishmaniasis; Gamma irradiation; Hydrogel; Delivery drug
资金
- National Nuclear Energy Commission (CNEN)
The study focused on analyzing the effects of Cobalt-60 gamma irradiation on crosslinking polymeric hydrogels containing Amphotericin B, in order to develop an alternative treatment method for leishmaniasis. The irradiated Hydg/Amph-B showed similar stability to the standard Amph-B solution and effectively inhibited L. amazonensis promastigotes, demonstrating its potential as a promising alternative therapy.
Amphotericin B (Amph-B) is an antifungal drug used intravenously for the treatment of leishmaniasis. Side-effects from Amph-B treatment can arise such as cardiac arrhythmia and renal dysfunctions, which will lead to discontinuation of treatment. Unfortunately, patients in endemic countries do not have access to alternative therapies. The objective of this study was to analyze the effects of Cobalt-60 gamma irradiation on crosslinking polymeric hydrogels (Hydg) and the incorporation of Amph-B into the gel as a controlled-release drug delivery alternative. Polyvinylpyrrolidone (PVP)/Amph-B solutions were irradiated with 15 kGy at 0 degrees C and 25 degrees C. The drug's stability was ascertained by UV-visible spectrometry, liquid chromatography/mass spectrometry and proton nuclear magnetic resonance. Irradiated Hydg/Amph-B achieved similar stability to the standard Amph-B solution and was enough to promote hydrogel crosslinking. In vitro trials were carried out to ensure Amph-B was still biologically active after irradiation. The results from flow cytometry and MTT assay show that Amph-B had an IC50 = 16.7 nM. A combination of Hydg at 1.324 gmL(-1) and Amph-B at 25.1 nM for 24 h lead to the greatest inhibition of L. amazonensis promastigotes, and could be used as an alternative treatment method for cutaneous leishmaniosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据